Neuroendocrine Differentiation in the Progression of Prostate Cancer: An Update on Recent DevelopmentsReportar como inadecuado




Neuroendocrine Differentiation in the Progression of Prostate Cancer: An Update on Recent Developments - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Neuroendocrine NE differentiation, either benign or malignant, is the hallmark of prostate cancer PCa. Clusters of malignant NE cells are found in most prostate cancer cases. NE differentiation is among the non-mutually exclusive theories proposed to explain the progression to androgen independence of PCa. NE differentiation is usually associated with an increased aggressivity and invasiveness of prostate tumors and a poor prognosis. This review aims to present an overview of current knowledge on neuroendocrine differentiation in PCa to improve our understanding of tumour progression and androgen independence. The NE component represents an important therapeutic axis. Development of new generation of drugs that selectively target NE-like cells may lead to the development of new therapeutic modalities for advanced and hormone-refractory PCa.

KEYWORDS

Prostate Cancer; Hormonal Therapy; Neuroendocrine; Neuroendocrine Differentiation; Neuropeptides; Chromogranin A; Tumorigenesis; Adenocarcinoma

Cite this paper

V. Perrot -Neuroendocrine Differentiation in the Progression of Prostate Cancer: An Update on Recent Developments,- Open Journal of Urology, Vol. 2 No. 3A, 2012, pp. 173-182. doi: 10.4236-oju.2012.223032.





Autor: Valérie Perrot

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados